Low Glycemic Index Prototype Isomaltulose—Update of Clinical Trials
AbstractLow glycemic index diets are supposed to achieve a more beneficial effect on blood glucose control in people with diabetes mellitus and may also provide metabolic benefits for the general population. A prototype of a low-glycemic index carbohydrate is the natural occurring disaccharide isomaltulose that can be commercially produced from sucrose (beet sugar) to industrial scale. It is currently used in various food and drink applications as well as special and clinical nutrition feeds and formula diet as a food ingredient and alternative sugar. Here we provide an overview on clinical trials with isomaltulose including an analysis of its effects on glycemia and fat oxidation as compared to high glycemic index sugars and carbohydrates. In addition, we discuss recent reports on beneficial effects in weight-loss maintenance and pregnancy. View Full-Text
A printed edition of this Special Issue is available here.
Share & Cite This Article
Maresch, C.C.; Petry, S.F.; Theis, S.; Bosy-Westphal, A.; Linn, T. Low Glycemic Index Prototype Isomaltulose—Update of Clinical Trials. Nutrients 2017, 9, 381.
Maresch CC, Petry SF, Theis S, Bosy-Westphal A, Linn T. Low Glycemic Index Prototype Isomaltulose—Update of Clinical Trials. Nutrients. 2017; 9(4):381.Chicago/Turabian Style
Maresch, Constanze Christin; Petry, Sebastian Friedrich; Theis, Stephan; Bosy-Westphal, Anja; Linn, Thomas. 2017. "Low Glycemic Index Prototype Isomaltulose—Update of Clinical Trials." Nutrients 9, no. 4: 381.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.